Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Ischemic Stroke
In brief
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and Food Effects of DA414 Granules in Chinese healthy subjects with single and multiple doses.
Key facts
- Study ID
- NCT06525168
- Run by
- Chendu DIAO Nine Hong Pharmaceutical Factory
- People needed
- 82
- Starts
- 2024-02-06
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2024-07-29
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China — Wuhan, Hubei.China, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.